Janiczek Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-45
Closed -$8.28K 1118
2024
Q1
$8.28K Hold
45
﹤0.01% 705
2023
Q4
$8.09K Hold
45
﹤0.01% 699
2023
Q3
$7.16K Hold
45
﹤0.01% 685
2023
Q2
$6.37K Hold
45
﹤0.01% 629
2023
Q1
$7.83K Buy
+45
New +$8.03K ﹤0.01% 613
2022
Q2
Sell
-22
Closed -$4K 1055
2022
Q1
$4K Sell
22
-23
-51% -$4.37K ﹤0.01% 708
2021
Q4
$12K Buy
45
+3
+7% +$808 ﹤0.01% 573
2021
Q3
$12K Buy
42
+8
+24% +$2.05K ﹤0.01% 550
2021
Q2
$7K Sell
34
-29
-46% -$5.63K ﹤0.01% 620
2021
Q1
$12K Sell
63
-102
-62% -$20.9K ﹤0.01% 497
2020
Q4
$32K Buy
165
+144
+686% +$26.2K 0.02% 271
2020
Q3
$3K Buy
+21
New +$3K ﹤0.01% 464

Other funds holding RGEN

Janiczek Wealth Management's RGEN Position: Q2 2024 in Review

Janiczek Wealth Management sold out of Repligen (RGEN) in Q2 2024, closing a stake of 45 shares — an estimated $8.28K sold.

Janiczek Wealth Management first reported a position in RGEN in Q3 2020 and held it in 12 quarters. The position peaked at $32K in Q4 2020. 453 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Janiczek Wealth Management reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Janiczek Wealth Management sold 45 Repligen shares in Q2 2024, an estimated $8.28K.
  • Janiczek Wealth Management first reported a position in Repligen in Q3 2020 and held it in 12 quarters.
  • Janiczek Wealth Management's Repligen position peaked at $32K in Q4 2020.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.